Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
BackgroundOvarian cancer is a deadly female malignancy with a high rate of recurrent and chemotherapy-resistant disease. Tumor-associated macrophages (TAMs) are a significant component of the tumor microenvironment and include high levels of M2-protumor macrophages that promote chemoresistance and m...
Main Authors: | David Schweer, Namrata Anand, Abigail Anderson, J. Robert McCorkle, Khaga Neupane, Alexandra N. Nail, Brock Harvey, Kristen S. Hill, Frederick Ueland, Christopher Richards, Jill Kolesar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1042730/full |
Similar Items
-
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma
by: Namrata Anand, et al.
Published: (2023-02-01) -
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
by: David Schweer, et al.
Published: (2022-04-01) -
Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention
by: Desheng Tang, et al.
Published: (2022-06-01) -
The number of CD163 positive macrophages is associatedwith more advanced skin melanomas, microvessels density and patient prognosis
by: Maciej Foks, et al.
Published: (2019-12-01) -
Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer
by: Carla Jorquera-Cordero, et al.
Published: (2022-05-01)